The Report Covers Global Ophthalmic Equipment Market Growth & Companies. The Market is Segmented by Devices (Surgical Devices (Glaucoma Drainage Devices, Glaucoma Stents and Implants, Intraocular Lenses, Lasers, and Other Surgical Devices), Diagnostic and Monitoring Devices (Autorefractors and Keratometers, Corneal Topography Systems, Ophthalmic Ultrasound Imaging Systems, Ophthalmoscopes, Optical Coherence Tomography Scanners, Other Diagnostic and Monitoring Devices), Vision Correction Devices (Spectacles and Contact Lenses) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Value is Provided in Terms of (USD Million) for the Above Segments.

The global ophthalmic diagnostic equipment market size is projected to be worth US$ 4,851.00 million by 2034. The market is anticipated to exhibit a 3.50% CAGR until 2034. In 2024, the market is expected to be valued at US$ 3,439.00 million.

Category-wise Insights

Country-wise Insights

The global ophthalmic devices market size reached USD 28.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 39.7 Billion by 2033, exhibiting a growth rate (CAGR) of 3.52% during 2025-2033. The market is propelled by the expanding geriatric population, rising prevalence of eye ailments, and the growing medical tourism sector which is driving innovation and investment in advanced eye care technologies.

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2025-2033. Our report has categorized the market based on product type, application, and end use.

The report covers UK Ophthalmology & Ophthalmology Marketing and the market is segmented by Devices (Surgical Devices (Glaucoma Drainage Devices, Glaucoma Stents and Implants, Intraocular Lenses, Lasers, and Other Surgical Devices), Diagnostic and Monitoring Devices (Autorefractors and Keratometers, Corneal Topography Systems, Ophthalmic Ultrasound Imaging Systems, Ophthalmoscopes, Optical Coherence Tomography Scanners, and Other Diagnostic and Monitoring Devices), and Vision Correction Devices(Spectacles and Contact Lenses)). The market provides the value (in USD million) for the above-mentioned segments.

Global ophthalmic equipment market size was valued at USD 61.1 billion in 2021 and is expected to grow at a CAGR of 4.8% during the forecast period.

Ophthalmic Equipment Market by Product Type (Vision Care, Surgical Devices {Refractive, Cataract, Vitreoretinal, Glaucoma, Accessories}, Diagnostic {Retinoscope, Tonometer, Ultrasound}), End User (Consumer, Clinic, Hospital) - Global Forecast to 2032

Global Ophthalmic Devices Market to hit USD 70.64B by 2029 growing at 8.1% CAGR. Explore trends, drivers, and competition for strategic insights with The Business Research Company.

The India Ophthalmology Devices Market is Segmented by Device (Surgical Device, Diagnostic and Monitoring Device, and Vision Care). The Report Offers the Value (in USD Million) for the Above Segments.

The size of the India Ophthalmology Devices Market was valued at USD XX Million in 2023 and is projected to reach USD XXX Million by 2032, with an expected CAGR of 7.30% during the forecast period. Indian Ophthalmology Devices Market: Among the rapidly growing products in the health industry, the market for ophthalmology devices is growing due to soaring disposable incomes and increasing eye diseases, coupled with rising awareness levels for eye care. Medical instruments and technologies used for diagnosis, treatment, and management of various eye conditions come under the umbrella of ophthalmology devices. These devices include intraocular lenses (IOLs), diagnostic equipment that spans from OCT, to fundus cameras and visual field analyzers, surgical instruments that consist of phacoemulsifiers and laser systems, contact lenses, and ophthalmic drugs. These include a wide variety of diseases that are addressed by ophthalmology, devices that include cataracts, glaucoma, diabetic retinopathy, age-related macular degeneration (AMD), and refractive errors. For example, IOLs are implanted in cataract surgeries to replace the cloudy lens and restore one's vision. Diagnostic equipment helps to make early diagnoses and monitor the diseases of the eye so that appropriate measures are taken in time. Operations are carried out with surgical instruments, which have made operations practically painless with minimal invasion, preventing a longer recovery time and improved patient outcome. Contact lenses correct what is commonly termed as refractory errors: myopia, hypermetropia, and astigmatism. Ophthalmic drugs treat conditions such as dry eye syndrome and infections where the eyes are uncomfortable and unhealthy, or glaucoma. Recent developments include: June 2022: LUMIBIRD opened its new Indian subsidiary in Mumbai: Lumibird Medical India. This company aims to boost the sales of Quantel Medical and Ellex products in India which has a vast range of ultrasound platforms, ophthalmic lasers and equipment for the diagnosis and treatment of dry eye disease., January 2022: Alcon launched the presbyopia-correcting intraocular lens (PC-IOL) with wavefront-shaping technology, the AcrySof IQ Vivity IOL (Vivity), in India.. Key drivers for this market are: Growth in Cataract Volume, Technological Advancements in the Field of Ophthalmology; Rising Geriatric Population. Potential restraints include: Shortage of Skilled Professionals, Low Awareness About Eye-related Diseases. Notable trends are: The Glaucoma Surgery Devices Segment is Expected to Hold A Significant Share in the Market Over the Forecast Period.

The Saudi Arabia ophthalmic devices market size reached USD 265.4 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 469.0 Million by 2033, exhibiting a growth rate (CAGR) of 6.53% during 2025-2033. The expanding healthcare industry, along with the inflating application of intraocular lenses (IOLs) to restore both near and distant vision, is primarily driving the ophthalmic devices market.

According to Cognitive Market Research, the global Ophthalmology market size is USD 55152.2 million in 2024 and will expand at a compound annual growth rate (CAGR) of 6.80% from 2024 to 2031.

North America held the major market of more than 40% of the global revenue with a market size of USD 22060.88million in 2024 and will grow at a compound annual growth rate (CAGR) of 5.0% from 2024 to 2031.
Europe accounted for a share of over 30% of the global market size of USD 16545.66million.
Asia Pacific held the market of around 23% of the global revenue with a market size of USD 12685.01 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.8% from 2024 to 2031.
Latin America market of more than 5% of the global revenue with a market size of USD 2757.61million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.2% from 2024 to 2031.
Middle East and Africa held the major market ofaround 2% of the global revenue with a market size of USD 1103.04million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031.
The hospitals held the highest Ophthalmology market revenue share in 2024.

Market Dynamics of Ophthalmology Market

Key Drivers of Ophthalmology Market

Rising Incidence of Eye Disorders to Increase the Demand Globally

The increasing prevalence of eye disorders such as cataracts, glaucoma, macular degeneration, and diabetic retinopathy is a significant driver in the ophthalmology market. Factors such as aging populations, unhealthy lifestyles, and the rising prevalence of chronic diseases like diabetes contribute to the growing burden of eye diseases worldwide. As a result, there is a higher demand for ophthalmic treatments, diagnostics, and surgical procedures. This trend is particularly pronounced in emerging economies where access to eye care services may be limited, leading to a surge in demand for ophthalmic products and services.

Technological Advancements in Ophthalmic Devices to Propel Market Growth

Technological advancements in ophthalmic devices have revolutionized the diagnosis, treatment, and management of eye diseases, driving growth in the ophthalmology market. Innovations such as optical coherence tomography (OCT), femtosecond lasers for cataract surgery, and minimally invasive glaucoma surgeries (MIGS) have enhanced the precision, safety, and effectiveness of ophthalmic procedures. These advancements not only improve patient outcomes but also enable ophthalmologists to offer more advanced and efficient treatments. Moreover, the increasing adoption of teleophthalmology and artificial intelligence (AI) in ophthalmic diagnostics further contributes to market growth by improving access to eye care services and enhancing diagnostic accuracy.

Restraint Factors of Ophthalmology Market

High Cost of Ophthalmic Treatments to Limit the Sales

One of the key restraints in the ophthalmology market is the high cost associated with ophthalmic treatments and procedures. Advanced ophthalmic surgeries, such as laser-assisted cataract surgery or retinal detachment repair, can be expensive, making them inaccessible to a significant portion of the population, especially in developing countries where healthcare infrastructure may be lacking. Additionally, the cost of ophthalmic medications, including eye drops for glaucoma or anti-VEGF injections for macular degeneration, can pose a financial burden on patients, particularly those without adequate insurance coverage. The high out-of-pocket expenses for ophthalmic care may deter patients from seeking timely treatment, leading to delayed diagnosis and progression of eye diseases.

Impact of Covid-19 on the Ophthalmology market

The Covid-19 pandemic has had a significant impact on the ophthalmology market worldwide. With healthcare systems overwhelmed by the pandemic, non-urgent ophthalmic procedures and appointments were postponed or canceled, leading to a decline in patient visits to ophthalmologists and eye clinics. Additionally, the implementation of social distancing measures and lockdowns resulted in reduced foot traffic in optical retail stores, affecting the sales of eyewear products. Moreover, the economic downturn caused by the pandemic led to financial constraints for both patients and healthcare facilities, further dampening demand for ophthalmic products and services. However, with the gradual easing of restriction...

Snapshot img

Ophthalmology Surgical Devices Market Size 2024-2028

The ophthalmology surgical devices market size is forecast to increase by USD 2.81 billion at a CAGR of 5.21% between 2023 and 2028.

The market is witnessing significant growth due to the increasing prevalence of ophthalmic diseases. According to the National Eye Institute, around 285 million people worldwide are estimated to be visually impaired, with 80% of cases attributable to preventable causes. This trend is driving the demand for advanced surgical devices to address various eye conditions. Strategic collaborations and mergers and acquisitions among market companies are also contributing to market growth. However, high costs and limited reimbursements pose challenges to the market expansion. Despite these hurdles, the market is expected to continue its upward trajectory due to the unmet medical needs and technological advancements In the field of ophthalmology.

What will be the Size of the Ophthalmology Surgical Devices Market During the Forecast Period?

Request Free SampleThe market encompasses a range of advanced technologies designed to address various eye disorders, including cataracts, glaucoma, and diabetic retinopathy. Key market drivers include the growing prevalence of ophthalmic disorders, particularly among the geriatric population, and the increasing demand for minimally invasive surgical procedures. Cataract surgeries, which involve the implantation of intraocular lenses, remain a significant segment of the market due to the high incidence of advanced cataracts and the resulting symptoms such as blurred vision, glare, and visual changes. Microscopes and robotic technologies are also gaining traction, enabling more precise and efficient ophthalmic surgeries. The backlog of patients seeking consultations for ocular disorders continues to fuel market growth.Symptoms like eye redness, refractive errors, and symptoms related to diabetes and other conditions further expand the market scope. Laser surgery and the development of advanced artificial lenses continue to shape the market landscape.

How is this Ophthalmology Surgical Devices Industry segmented and which is the largest segment?

The ophthalmology surgical devices industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments. ProductCataract surgery devicesGlaucoma surgery devicesRefractive surgery devicesVitreoretinal surgery devicesGeographyNorth AmericaUSEuropeGermanyUKAsiaChinaJapanRest of World (ROW)

By Product Insights

The cataract surgery devices segment is estimated to witness significant growth during the forecast period.

Ophthalmology surgical devices play a crucial role in addressing various eye disorders, including cataracts and glaucoma. Cataracts, a leading cause of vision impairment, affect individuals due to aging or eye injuries, and are associated with symptoms such as blurred vision, difficulty reading, and visual changes. According to the National Eye Institute, over 24.4 million Americans aged 40 and above have cataracts. Glaucoma, another prevalent ophthalmic disorder, affects over 3 million Americans and results in severe visual impairment or blindness if left untreated. Advanced technologies like microscopes, robotic technologies, and laser technology are transforming ophthalmic surgeries, including cataract surgeries utilizing phacoemulsification systems and intraocular lenses.Technological advancements, such as SmartCataract solutions and the Hydrus Microstent for glaucoma, offer innovative alternatives for managing ophthalmic disorders. The geriatric population, with its increasing prevalence of cataracts and glaucoma, drives the demand for these surgical devices. The ophthalmic equipment market encompasses a wide range of surgical products, including vitreoretinal surgery devices, ophthalmology drugs, and glaucoma surgical devices. The aging population and the increasing prevalence of eye disorders, such as cataract, diabetic retinopathy, and macular degeneration, necessitate advancements in ophthalmic equipment.

Get a glance at the Ophthalmology Surgical Devices Industry report of share of various segments Request Free Sample

The Cataract surgery devices segment was valued at USD 3.4 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 43% to the growth of the global market during the forecast period.

Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions, Request Free Sample

The North American the market is experiencing significant growth due to increasing healt

The Ophthalmology Drug and Device Market are Segmented by Product (devices and Drugs), Disease (Glaucoma, Cataract, Age-Related Macular Degeneration, Inflammatory Diseases, Refractive Disorders, and Other Diseases), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Report Offers the Value in ( USD Million) for the Abovementioned Segments.

China Ophthalmic Devices Market Outlook 2031:

The China ophthalmic devices market size was valued at USD 4.51 Billion in 2022 and is projected to reach USD 9.47 Billion by 2031, expanding at a CAGR of 8.59% during the forecast period 2023 - 2031. The growth of the market is attributed to the increasing prevalence of eye disorders and vision loss.

Ophthalmology is known to be a field of clinical science that handles function, structure, and several eye diseases. Ophthalmic devices are clinical instruments that analyze and treat conditions of eyes.

They can be used with an eye-care professional’s supervision, but some can also be self-administered by patients as part of home care. These ranges from simple tonometers to laser surgical systems for correcting eyesight issues such as myopia and hypermetropia, utilized during medical procedures along different items.



At the point when the World Health Organization (WHO) declared Covid-19 as an overall pandemic in March 2020, routine medical care arrangements were kept away to keep patients from getting the infection, and ophthalmology services were especially affected.



Numerous strategies are elective and most patients are older and in risk of experiencing Covid-19 side effects. As the pandemic proceeds with an anticipated ‘third wave,’ ophthalmologists are endeavoring to reduce the backlog of strategies while adhering to safety protocols. The Covid-19 pandemic can prompt a long-term change in the ophthalmology market.

Ophthalmic Devices Market Trends, Drivers, Restraints, and Opportunities

• Growing geriatric population is estimated to accelerate the growth of the market.


• <span style="font-size:11pt

Ophthalmic Devices market is expected to grow at a CAGR Of 10.1% during the forecast period 2024-2031 | DataM Intelligence

Global Diagnostic And Monitoring Ophthalmic Devices And Equipment Market to hit USD 6.78B by 2029 growing at 4.8% CAGR. Explore trends, drivers, and competition for strategic insights with The Business Research Company.

The report covers US America Ophthalmic Equipment Market Outlook and it is segmented by Devices (Surgical Devices, Diagnostic, and Monitoring Devices, and Vision Correction Devices). The market size and forecast values are provided in terms of (USD) for all the above segments.

Japan ophthalmic devices market size reached USD 1,691 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 2,024 Million by 2033, exhibiting a growth rate (CAGR) of 2% during 2025-2033. The rising awareness among individuals towards visual impairment, along with the rising reliance on consumer electronic devices, is primarily catalyzing the regional market.

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2025-2033. Our report has categorized the market based on product, application, and end user.

The size of the U.S. Ophthalmic Devices Market market was valued at USD 2.64 billion in 2023 and is projected to reach USD 3.55 billion by 2032, with an expected CAGR of 4.34 % during the forecast period. The instruments and equipments used for diagnosing, treating and managing eye disorders and diseases comprises the U. S. ophthalmic devices market. This market consists of diagnostic imaging system devices like OCT, fundus cameras; surgical devices like lasers and phacoemulsification machine; therapeutic devices such as intraocular lenses and contact lenses. Specializations cover everything from simple and routine Computer Vision Test and refractive surgery for eyeglasses to complex other surgeries including Cataract surgery, Glaucoma surgeries and Retinal surgery. Trends include increased use of the minimally invasive techniques, new diagnostic imaging technologies, need for new solutions such as personalized therapies and teleophthalmology. The market is also affected by an increasing incidence of ophthalmological diseases as well as the growing number of the population aged 60 and over. Recent developments include: In March 2024, Clario partnered with Cleveland Clinic’s Cole Eye Institute. This collaboration will support clinical trials evaluating the efficacy of therapeutics designed to treat the eye as well as other trials monitoring ophthalmic safety events. , In October 2023, Bausch + Lomb announced the launch of SeeNa, an ophthalmic diagnostic system for refractive cataract patients in the U.S. This provides a new way for busy refractive cataract practices to enhance surgical planning efficiency. .